Integrated Filing — IndAS

General information about company
Scrip Code	543654
NSE Symbol	MEDANTA
MSEI Symbol	NOTLISTED
ISIN	INE474Q01031
Name of company	GLOBAL HEALTH LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	15-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	05-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Healthcare services
Start date and time of board meeting	15-May-2025   14:00:00
End date and time of board meeting	15-May-2025   16:00:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2025-02-04
Indicate Company website link for updated RPT policy of the Company	https://www.medanta.org/investor_relations/corporate-governance/governance-codes-policies
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
NO default on payment of loans.

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	8028680000	32041460000
	Other income	256660000	909290000
	Total income	8285340000	32950750000
2	Expenses
(a)	Cost of materials consumed	1723750000	7158130000
(b)	Purchases of stock-in-trade	58230000	403900000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	32070000	26240000
(d)	Employee benefit expense	1854160000	7462910000
(e)	Finance costs	70990000	333910000
(f)	Depreciation, depletion and amortisation expense	379800000	1496110000
(f)	Other Expenses
1	Retainers and consultants fee	1064640000	4038720000
2	Other expenses	1343870000	5301400000
	Total other expenses	2408510000	9340120000
	Total expenses	6527510000	26221320000
3	Total profit before exceptional items and tax	1757830000	6729430000
4	Exceptional items	-498960000	-498960000
5	Total profit before tax	1258870000	6230470000
6	Tax expense
7	Current tax	368650000	1615530000
8	Deferred tax	-43900000	-340000
9	Total tax expenses	324750000	1615190000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	934120000	4615280000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	934120000	4615280000
17	Other comprehensive income net of taxes	-22600000	-9680000
18	Total Comprehensive Income for the period	911520000	4605600000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	537170000	537170000
	Face value of equity share capital	2	2
27	Details of debt securities
22	Reserves excluding revaluation reserve		34438910000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	3.48	17.18
	Diluted earnings (loss) per share from continuing operations	3.48	17.18
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	3.48	17.18
	Diluted earnings (loss) per share from continuing and discontinued operations	3.48	17.18
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	14663010000
	Capital work-in-progress	4535460000
	Investment property	0
	Goodwill	0
	Other intangible assets	48550000
	Intangible assets under development	41710000
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	3655080000
	Trade receivables, non-current
	Loans, non-current	0
	Other non-current financial assets	262950000
	Total non-current financial assets	3918030000
	Deferred tax assets (net)	140790000
	Other non-current assets	6530780000
	Total non-current assets	29878330000
2	Current assets
	Inventories	489950000
	Current financial asset
	Current investments	0
	Trade receivables, current	2915860000
	Cash and cash equivalents	1900650000
	Bank balance other than cash and cash equivalents	8627160000
	Loans, current	145870000
	Other current financial assets	286580000
	Total current financial assets	13876120000
	Current tax assets (net)	0
	Other current assets	161450000
	Total current assets	14527520000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	44405850000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	537170000
	Other equity	34438910000
	Total equity attributable to owners of parent	34976080000
	Non controlling interest
	Total equity	34976080000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	1143090000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	2256090000
	Total non-current financial liabilities	3399180000
	Provisions, non-current	633260000
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	209080000
	Total non-current liabilities	4241520000
	Current liabilities
	Current financial liabilities
	Borrowings, current	261330000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	711760000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	975060000
	Total Trade payable	1686820000
	Other current financial liabilities	1333670000
	Total current financial liabilities	3281820000
	Other current liabilities	1470880000
	Provisions, current	435550000
	Current tax liabilities (Net)
	Deferred government grants, Current
	Total current liabilities	5188250000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	9429770000
	Total equity and liabilites	44405850000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Re-measurement gain on defined benefit plans	-30200000	-12940000
	Total Amount of items that will not be reclassified to profit and loss	-30200000	-12940000
2	Income tax relating to items that will not be reclassified to profit or loss	-7600000	-3260000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss
5	Total Other comprehensive income	-22600000	-9680000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			6230470000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			333910000
	Adjustments for decrease (increase) in inventories			63550000
	Adjustments for decrease (increase) in trade receivables, current			-948870000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			0
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			-105650000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			114050000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			0
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			1496110000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			0
	Adjustments for provisions, non-current			130780000
	Adjustments for other financial liabilities, current			-153030000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			-3670000
	Adjustments for dividend income			0
	Adjustments for interest income			813120000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			40590000
	Other adjustments for non-cash items			498960000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			653610000
	Net cash flows from (used in) operations			6884080000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			1607410000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			5276670000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			39100000
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			23130000
	Purchase of property, plant and equipment			4276900000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			1313700000
	Cash advances and loans made to other parties			450000000
	Cash receipts from repayment of advances and loans made to other parties			85540000
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			788140000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-1199150000
	Net cash flows from (used in) investing activities	-6382040000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			160000
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			1150000000
	Repayments of borrowings			1718570000
	Payments of lease liabilities			63550000
	Dividends paid			0
	Interest paid			312950000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-944910000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-2050280000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-2050280000
	Cash and cash equivalents cash flow statement at beginning of period			3950930000
	Cash and cash equivalents cash flow statement at end of period			1900650000